Robaxin vs. Zanaflex
See how Robaxin and Zanaflex compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Robaxin is a carbamate muscle relaxant used for acute musculoskeletal pain, while Zanaflex is an alpha-2 agonist approved specifically for spasticity from conditions like multiple sclerosis or spinal cord injury.
Robaxin is not a controlled substance and costs less, while Zanaflex offers more targeted spasticity control with flexible, short-acting dosing.
Both drugs commonly cause dizziness and drowsiness, but Zanaflex also carries risks of liver toxicity and serious drug interactions that require monitoring.
Robaxin vs. Zanaflex Drug Summary
Robaxin
Robaxin (methocarbamol) is a centrally-acting carbamate muscle relaxant used alongside rest and physical therapy to relieve discomfort from acute musculoskeletal injuries. It comes as an oral tablet or an IV/IM injection, and the injectable form is also used as adjunct therapy for tetanus.
Zanaflex
Zanaflex (tizanidine) is a central alpha-2 adrenergic agonist approved to manage muscle spasticity in adults, often from conditions like multiple sclerosis or spinal cord injury. It is taken orally as a tablet or capsule, usually timed around specific activities since its effects wear off fairly quickly.
Robaxin vs. Zanaflex Side Effects
Robaxin
Zanaflex
Robaxin vs. Zanaflex Dosage
Robaxin
Zanaflex
| STAGE | DOSE | WHEN |
| Starting dose | 1500 mg four times daily | Days 1-3 |
| Maximum dose | 750 mg every 4 hours | Day 4 onward |
| Dose changes | 1 increase | Every 3 days |
| STAGE | DOSE | WHEN |
| Starting dose | 2 mg every 6-8 hours | At the start |
| Maximum dose | 2 mg every 6-8 hours | Same as starting |
| Dose changes | None | Fixed dose |
Robaxin
| STAGE | DOSE | WHEN |
| Starting dose | 1500 mg four times daily | Days 1-3 |
| Maximum dose | 750 mg every 4 hours | Day 4 onward |
| Dose changes | 1 increase | Every 3 days |
Zanaflex
| STAGE | DOSE | WHEN |
| Starting dose | 2 mg every 6-8 hours | At the start |
| Maximum dose | 2 mg every 6-8 hours | Same as starting |
| Dose changes | None | Fixed dose |
Robaxin vs. Zanaflex Indications
Robaxin
Robaxin is FDA-approved as an adjunct to rest and physical therapy for the discomfort of acute, painful musculoskeletal conditions, not for long-term pain management. The injectable form is also used as adjunct therapy in tetanus treatment. It is not approved for children under 16.
Relief of acute musculoskeletal pain and spasm
Adjunct to rest and physical therapy
Injectable form used in tetanus management
Not approved for chronic pain
Not approved under age 16
Zanaflex
Zanaflex is FDA-approved to manage spasticity in adults, commonly from multiple sclerosis or spinal cord injury. It is not approved for chronic musculoskeletal pain or for use in children. Its short duration of action makes it useful for dosing around specific tasks.
Management of spasticity in adults
Often used for MS-related spasticity
Often used for spinal cord injury spasticity
Short-acting, dosed around activities
Not approved for pediatric patients
Robaxin vs. Zanaflex Pros and Cons
Robaxin
Robaxin has a long safety record dating back to 1957 and is not a federally controlled substance, unlike some other muscle relaxants. It costs less than Zanaflex but requires more frequent dosing and is not approved for long-term or chronic pain.
Pros
Not a federally controlled substance
Available in oral and IV/IM injectable forms
Long-established safety history since 1957
Cons
Requires frequent dosing, up to four times daily
Not approved for chronic pain management
Less targeted for neurologic spasticity conditions
Zanaflex
Zanaflex is specifically approved for spasticity and offers flexible, short-acting dosing that can be timed to activities. It carries a higher cost than Robaxin and requires liver monitoring due to a hepatotoxicity risk.
Pros
FDA-approved specifically for spasticity from MS or spinal cord injury
Flexible dosing timed to specific activities
Generic available since 2002
Cons
Requires liver enzyme monitoring for hepatotoxicity risk
Can interact dangerously with CYP1A2 inhibitors
Higher cost: roughly $130 to $565 per month before insurance
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.